''Shen-Gu granule'' for the prevention and treatment of glucocorticoid-induced osteoporosis.
Phase 4
- Conditions
- Prevention and treatment of glucocorticoid-induced osteoporosis
- Registration Number
- ITMCTR2000003181
- Lead Sponsor
- Shanghai Tongji Hospital, Tongji University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with a recent history of GC or a recent plan to take glucocorticoids.
Exclusion Criteria
(1) patients with tumor, bone tuberculosis, fracture and other osteoporosis lesions or injuries;
(2) pregnant or lactating women;
(3) allergic constitution or allergic to the known ingredients of the drug;
(4) patients with heart, lung, liver, kidney, hematopoietic system, immune system and other serious diseases.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life:;Signs and symptoms related to traditional Chinese medicine;Dual-energy X-ray bone mineral density measurement (DXA);
- Secondary Outcome Measures
Name Time Method